Althea Wins $100,000 SBIR for New Gene Expression Technology | GenomeWeb

NEW YORK, May 5 - Althea Technologies said today that it has received a Phase I Small Business Innovation Research grant from the National Institutes of Health, via the National Cancer Institute, to develop a new high-throughput approach to gene expression analysis for cancer.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.